[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366648-105":59,"doc-detail-366648-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prevalence-of-glut1-overexpression-in-human-cancers-systematic-review-and-meta-analysis","Prevalence of GLUT1 overexpression in human cancers - systematic review and meta analysis","","Glucose transporter 1 (GLUT1) expression in cancers has inconsistent clinical significance, prompting a systematic evaluation of how GLUT1 overexpression relates to its prevalence in cancer tissues. Searches of MEDLINE and the Cochrane Library (up to May 30, 2024) identified observational studies and RCTs. Random-effects analyses estimated risk ratios with 95% confidence intervals, with subgroup analyses by cancer type and geography. Publication bias and sensitivity were assessed, focusing on diagnostic value versus normal tissues.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prevalence-of-glut1-overexpression-in-human-cancers-systematic-review-and-meta-analysis/366648/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prevalence-of-glut1-overexpression-in-human-cancers-systematic-review-and-meta-analysis/366648.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of this systematic review and meta-analysis?","Question",{"text":113,"@type":114},"To evaluate the association between GLUT1 overexpression and its prevalence in cancer tissues and to clarify its potential diagnostic significance compared with normal tissues.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many studies and patients were included?",{"text":118,"@type":114},"Seventeen studies with a total of 1,795 patients were included.",{"name":120,"@type":111,"acceptedAnswer":121},"Which cancer types showed the highest prevalence of GLUT1 overexpression?",{"text":122,"@type":114},"Urological cancers showed the highest prevalence, followed by head and neck cancers, and gynecological cancers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},366648,1790211146,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Yuan et al. Discover Oncology (2025) 16:1761 [https://doi.org/10.1007/s12672-025-03473-4](https://doi.org/10.1007/s12672-025-03473-4)  \nDiscover Oncology  \nRESEARCH Open Access  \nPrevalence of GLUT1 overexpression in human  cancers a systematic review and meta analysis  \nQuan Yuan 1†, Hongzhi Liu2†, Canxu Song 1, Yan Tian 1, Waseem Hassan3, Ramla Shabbir4, Chen Wenjuan 1 and Le Han 1,2*  \n\n| †Quan Yuan and Hongzhi Liu contributed equally to this work. |\n| --- |\n| †Chen Wenjuan and Le Han have equal contribution as correspond author. |\n\n*Correspondence: Le Han [millyhan1@sohu.com](millyhan1@sohu.com)  \n1Shaanxi Cancer Hospital Affiliated to Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, Shaanxi, China  \n2Shaanxi University of Chinese Medicine, No. 1 Weiyang East Road, Xianyang 712046, Shaanxi, China 3Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore  \n54000, Pakistan  \n4Faculty of Pharmacy, The University of Lahore, Lahore 54000, Pakistan  \nAbstract  \nBackground The clinical significance of glucose transporter 1 (GLUT1) expression in cancers remains controversial due to inconsistent findings. This meta-analysis systematically evaluates the association between GLUT1 overexpression and its prevalence in cancer tissues, highlighting its potential role as a diagnostic biomarker. Methods A comprehensive search of MEDLINE and the Cochrane Library was performed up to May 30, 2024, to identify observational studies and RCTs examining the association of GLUT1 expression with its prevalence in cancer tissues. Data were analyzed using random-effects models, and results were presented as Risk Ratios (RRs) with 95% confidence intervals (CIs) . Subgroup analyses were performed based on cancer types and geographical locations. This meta-analysis focused on the diagnostic significance of GLUT1 expression in distinguishing cancer tissues from normal tissues. Publication bias and sensitivity analyses were assessed.  \nResults Seventeen studies with 1,795 patients were included. GLUT1 overexpression was significantly associated with its prevalence in cancer tissues compared to normal tissues (RR = 5 . 57, 95% CI = 3 .42–9. 09, P \u003C 0. 001) . Subgroup analysis showed the highest prevalence in urological cancers (RR = 20 . 56, 95% CI = 10 .85–38. 93), followed by head and neck cancers (RR = 18 . 00, 95% CI = 2 .66–121. 63), and gynecological cancers  \n(RR = 10 . 55, 95% CI = 2 .06–54. 00) . Geographical analysis indicated a stronger association in Europe (RR = 24 . 18, 95% CI = 13 .37–43. 73) than in East Asia (RR = 6 . 16, 95% CI = 2 .69– 14. 15) and North America (RR = 1 . 90, 95% CI = 1 .32–2. 73) . This analysis evaluates the diagnostic significance of GLUT1 expression in cancer tissues. Evidence of publication bias was detected based on Egger’s test (z = 4 . 667, p \u003C 0. 001), suggesting funnel plot asymmetry.  \nConclusion GLUT1 overexpression is associated with its high prevalence in cancer tissues, particularly in urological and head and neck cancers. These findings suggest that GLUT1 may serve as a potential diagnostic biomarker in oncology. However, this study does not evaluate survival outcomes (such as overall survival or progression-free survival), and further research is needed to determine its diagnostic significance and therapeutic potential.  \nKeywords GLUT1, Cancer diagnosis, Meta-analysis, Glucose metabolism, Biomarker  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party mat","cbCair0PrRZ2sKYs","https://ap.wps.com/l/cbCair0PrRZ2sKYs","pdf",3101014,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the main objective of this systematic review and meta-analysis?\",\"answer\":\"To evaluate the association between GLUT1 overexpression and its prevalence in cancer tissues and to clarify its potential diagnostic significance compared with normal tissues.\"},{\"question\":\"How many studies and patients were included?\",\"answer\":\"Seventeen studies with a total of 1,795 patients were included.\"},{\"question\":\"Which cancer types showed the highest prevalence of GLUT1 overexpression?\",\"answer\":\"Urological cancers showed the highest prevalence, followed by head and neck cancers, and gynecological cancers.\"}]","Prevalence of GLUT1 overexpression in human cancers - systematic review and meta analysis | PDF",1790166562,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2d07cad9f6652f7f440355c6bd3bfd9.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/572a3e6e252ec36271b914a678244adf.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ebe6f864db3448e086a40b6418bf09b.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a22e26f93367f5f711ee93d2b98bbdd8.webp",980,1306]